Related Experiment Video
Updated: Dec 20, 2025
07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
8.8K
Evolutionary conservation and functional impact of dopamine D2 receptor
1Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, China.
Neuroscience Letters
|May 27, 2020
Summary
Evolutionary analysis reveals that sub-family conserved residues in dopamine D2-like receptors (D2) are crucial for disease development. These findings enhance understanding of dopamine receptor function and disease mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Evolutionary Biology
Background:
- Dopamine D2-like receptors (D2) are critical mediators of dopamine's diverse biological effects.
- Understanding the structural and functional regions of D2 receptors is key to elucidating dopamine's mechanism of action.
Purpose of the Study:
- To characterize evolutionary conserved regions within dopamine D2-like receptors.
- To evaluate the significance of conserved residues and motifs in relation to structural stability, genetic variants, function, and drug binding.
Main Methods:
- A large-scale phylogenetic analysis was performed on D2 receptor data.
- Evolutionary conserved residues were identified at both super-family and sub-family levels.
- A 3D structure model of the human D2 receptor (DRD2) was generated to assess conserved residue significance.
Main Results:
- Drug binding sites and protein-complex interaction motifs exhibited super-family conservation.
- Genetic variants associated with diseases were predominantly found within sub-family conserved regions.
- The extracellular loop 3 (ECL3) domain displayed both super-family and sub-family conserved residues.
Conclusions:
- Sub-family conserved residues are strongly implicated in the incidence and progression of diseases.
- These findings highlight the specific roles of evolutionary conserved regions in D2 receptor function and disease pathology.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
2.0K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K
01:20Evolutionary Psychology
804
Evolutionary psychology explores the origins of human behavior and mental processes by framing them within the context of natural selection, a theory famously propounded by Charles Darwin. This field asserts that many behaviors common across human societies — ranging from instinctive fear reactions to complex social interactions — arose as evolutionary adaptations. These adaptations enhanced the survival and reproductive success of our ancestors, thereby becoming embedded in the...
804
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.4K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.4K
01:03Dose-Response Relationship: Overview
4.6K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.6K
01:30Spare Receptors
4.4K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.4K
01:49Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K